Image source: © 2025 Krish Capital Pty. Ltd.

Highlights

  • PGC reported 1HFY25 revenue of AUD 1,850.4 million, up 28.4% YoY.
  • The company targets AUD 5 million in FY25 and AUD 12 million in FY26 synergies through integration.
  • PGC remains focused on margin improvement, cost control, and strategic acquisitions.

Paragon Care Limited (ASX:PGC) is an Australia-based healthcare company supplying medical equipment, consumables, pharmaceuticals, and maintenance services across hospitals, aged care, veterinary, and diagnostic sectors in Australia, New Zealand, and Asia, including distribution of complementary medicines.

In the first half of the financial year 2025 (1HFY25), PGC reported revenue of AUD 1,850.4 million, up 28.4% YoY from AUD 1,440.8 million in 1HFY24, driven by Asia segment growth, pharmacy performance, and diagnostic expansion.  EBITDA more than doubled to AUD 47.5 million in 1HFY25, marking a 103.0% YoY increase from AUD 23.4 million. Meanwhile, net profit after tax rose 85.9% to AUD 13.2 million, up from AUD 7.1 million in the prior corresponding period.

Business Update

PGC is expected to release its full-year financial results for the period ended 30 June 2025 on Wednesday, 27 August 2025, as announced in its FY25 business update dated 22 July 2025.

In a leadership change announced on 25 June 2025, PGC appointed Carmen Riley as Chief Executive Officer and Executive Director, effective 1 July 2025. Riley, formerly the Chief Operating Officer/Executive Director following the merger with Clifford Hallam Healthcare Pty Ltd, brings 15 years of senior experience to the role.

Company Outlook

PGC will progress with its ongoing integration plan, targeting AUD 5 million in FY25 and AUD 12 million in FY26 synergies through operational streamlining and system consolidation. The company remains focused on organic growth by expanding bundled product offerings to a wider customer base.

To enhance EBITDA margins, PGC is prioritising cost control, supply chain optimisation, and rationalisation of role overlap. The company is also actively reviewing its customer, product, and agency partner pipeline while maintaining a proactive acquisition strategy to support long-term strategic growth.

Share performance of PGC

PGC shares declined by 2.50% to close at AUD 0.390 on 7 August 2025. Over the past year, PGC’s share price has dropped 12.36%, with steeper declines of 18.75% over the past nine months and 27.78% over the past six months. The 52-week high for PGC is AUD 0.590, reached on 3 February 2025, while the 52-week low is AUD 0.345, recorded on 26 June 2025.

Support and Resistance Summary

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency, is 07 August 2025. The reference data in this report has been partly sourced from EODHD/Others.

 

Technical Indicators Defined:

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.